5 min

Michelle Claire Williams
Edinburgh, United Kingdom

Gudrun Zahlmann
Neumarkt, Germany

Chairpersons’ introduction

15 min

Richard Ehman
Rochester, Minnesota, United States

Quantitative imaging biomarkers in MASH: from concept to clinical criteria

1. To learn the principles behind quantitative imaging biomarkers and their potential role in assessing MASH.
2. To appreciate how imaging biomarkers can support diagnostic confidence and clinical decision-making in MASH.
3. To understand the criteria and challenges for validating imaging biomarkers as surrogate endpoints in clinical trials and routine care.

15 min

Lukas Müller
Mainz, Germany

Monitoring MASH progression and treatment response with quantitative imaging

1. To learn about imaging techniques currently used to quantify liver fat, inflammation, and fibrosis in MASH.
2. To appreciate the strengths and limitations of quantitative imaging for monitoring disease evolution and therapeutic response.
3. To understand how imaging biomarkers can complement or replace biopsy in longitudinal assessment of MASH.

15 min

Giovanna Ferraioli
Pavia, Italy

Quality, standardisation, and best practices in quantitative ultrasound imaging for MASH

1. To learn the importance of quality assurance and quality control (QA/QC) in quantitative liver imaging.
2. To appreciate the parallels between standardisation in imaging and laboratory-based diagnostics.
3. To understand current initiatives and frameworks for ensuring reproducibility and cross-centre consistency in quantitative imaging measurements.

10 min

Panel Discussion

What are the barriers to implementing quantitative imaging in MASH?